Persistent URL of this record https://hdl.handle.net/1887/95572
In Collections
This item can be found in the following collections:
The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome
- All authors
- Wilde, S. de; Jong, M.G.H. de; Lipka, A.F.; Guchelaar, H.J.; Schimmel, K.J.M.
- Date
- 2018-03-01
- Volume
- 114
- Pages
- 24 - 29